Dr. Ho is an associate professor of medicine in the Division of Hematology/Oncology, Department of Internal Medicine at Mayo Clinic, Phoenix, Arizona.
Recognizing hereditary syndromes in renal cell carcinoma
Patients may require specific diagnostic, surveillance, and therapeutic management.
How to choose systemic therapy for metastatic RCC
Combination therapy is the first-line standard for metastatic renal cell carcinoma.
Survey: New NMIBC treatments face slow uptake
RCT compares platinum/5-FU, platinum/paclitaxel in high-risk penile cancer
FDA updates in urology: May 2025
NIAGARA: ctDNA analysis highlights durvalumab’s impact in MIBC